Protagonist Therapeutics, Inc. (PTGX)

83.12 -0.37 (-0.44%) USD  |  NASDAQ  |  Feb 12, 11:08
More

Protagonist Therapeutics EPS Diluted (Quarterly YoY Growth)

EPS Diluted (Quarterly YoY Growth) Chart

View EPS Diluted (Quarterly YoY Growth) for PTGX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years

View EPS Diluted (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly YoY Growth) Benchmarks

View EPS Diluted (Quarterly YoY Growth) Benchmarks
Start Trial
ADMA Biologics, Inc. Upgrade
Johnson & Johnson Upgrade
Glaukos Corp. Upgrade
Krystal Biotech, Inc. Upgrade
TransMedics Group, Inc. Upgrade